NEU 15.7% $23.97 neuren pharmaceuticals limited

An aquirer will likely have many other parts. So the exposure...

  1. 5,722 Posts.
    lightbulb Created with Sketch. 272


    An aquirer will likely have many other parts. So the exposure for Neurens assets would be highly diluted if a current shareholder invested in the aquirer.

    Thus it would`t be effective. IMO

    Best to get the maximum possible when/if TO occurs. Not good enough offer, send `em packing.

    It will really depend if there is more than 1 suitor.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$23.97
Change
3.260(15.7%)
Mkt cap ! $3.060B
Open High Low Value Volume
$23.00 $24.00 $21.60 $27.11M 1.181M

Buyers (Bids)

No. Vol. Price($)
2 942 $23.95
 

Sellers (Offers)

Price($) Vol. No.
$23.97 27 1
View Market Depth
Last trade - 16.10pm 27/05/2024 (20 minute delay) ?
Last
$24.00
  Change
3.260 ( 16.0 %)
Open High Low Volume
$22.98 $24.00 $21.60 310545
Last updated 15.59pm 27/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.